Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
117 Cards in this Set
- Front
- Back
|
Acetaminophen (tylenol)
Class |
Anaglesic, Antipyretic
|
|
|
Acetaminophen
Mechanism of Action? |
Analgesia: not clearly defined
Antipyresis: inhibition of the effect of endogenous pyrogens on CNS heat-regulating centers |
|
|
Acetaminophen (tylenol)
indications? |
Indications
- mild to moderate pain - fever |
|
|
Acetaminophen (tylenol)
Contraindications |
Contraindications
- hypersensitivity to acetaminophen |
|
|
Acetaminophen (tylenol)
Adverse Reactions |
Adverse Reactions
- no significant adverse reactions noted at therapeutic doses |
|
|
Acetaminophen (tylenol)
Drug Interactions |
Drug Interactions
- no significant drug interactions from a single therapeutic dose |
|
|
Acetaminophen (tylenol)
How Supplied |
How Supplied
- liquid: 80 mg/ml (drops), 160 mg/5ml (syrup) - tablets: 325 mg/tab, 500 mg/tab |
|
|
Acetaminophen (tylenol)
Dosage and Administration |
Dosage and Administration
- given as a single oral dose - Age-based: 4 – 11 months: 80 mg 12 – 23 months: 120 mg 2 – 3 years: 160 mg 4 – 5 years: 240 mg 6 – 8 years: 320 mg 9 – 10 years: 400 mg 11 – 12 years: 480 mg >12 years: 650 mg - If weight known: - 15 mg/kg, Maximum 1000mg (may round off to nearest 10 mg) |
|
|
Acetaminophen (tylenol)
Duration of Action |
Duration of Action
- onset: 30 minutes - peak effect: variab |
|
|
Acetaminophen (tylenol)
Special Considerations |
Special Considerations
- pregnancy safety: Over 40 years of clinical experience, available data indicate that acetaminophen in therapeutic doses does not adversely affect the pregnant mother or the fetus. |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
Class |
Class
- platelet inhibitor, anti-inflammatory agent |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
Mechanism of Action |
Mechanism of Action
- prostaglandin inhibition, prevents platelet aggregation |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
Indications |
Indications
- chest pain suggestive of acute MI - patient with previous cardiac history presenting with chest pain consistent with cardiac ischemia unrelieved by nitroglycerine |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
Contraindications |
Contraindications
- hypersensitivity to ASA or nonsteroidal anti-inflammatory drugs (NSAIDs) - gastrointestinal bleeding |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
Adverse Reactions |
Adverse Reactions
- heartburn - GI bleeding - nausea, vomiting - wheezing in allergic patients - prolonged bleeding |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
Drug Interactions |
Drug Interactions
None |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
How Supplied |
How Supplied
- 80 mg, 160mg, or 325 mg tablets (chewable and standard) |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
Dosage and Administration |
Dosage and Administration
- 160 mg PO |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
Duration of Action |
Duration of Action
- onset: 30 - 45 minutes - peak effect: variable - duration: life of platelet (7 - 10 days) |
|
|
ACETYLSALICYLIC ACID (ASPIRIN, ASA)
Special Considerations |
Special Considerations
- pregnancy safety: category D - not recommended in pediatric population |
|
|
DIPHENHYDRAMINE (BENADRYL)
Class: |
Class:
- antihistamine, anticholinergic, |
|
|
DIPHENHYDRAMINE (BENADRYL)
Mechanism of Action |
Mechanism of Action
- blocks cellular histamine receptors - decreases vasodilation - decreases motion sickness - reverses extrapyramidal reactions |
|
|
DIPHENHYDRAMINE (BENADRYL)
Indications |
Indications
- symptomatic relief of allergies, allergic reactions, anaphylaxis, acute dystonic reactions due to phenothiazines, motion sickness |
|
|
DIPHENHYDRAMINE (BENADRYL)
Contraindications |
Contraindications
- glaucoma, hypertension, narrow angle glaucoma, infants - patients taking monoamine oxidase inhibitors |
|
|
DIPHENHYDRAMINE (BENADRYL)
Adverse Reactions |
Adverse Reactions
- sedation, hypotension, seizures, visual disturbances, vomiting, urinary retention, palpitations, dysrhythmias, dry mouth and throat - paradoxical CNS excitation in children |
|
|
DIPHENHYDRAMINE (BENADRYL)
Drug Interactions |
Drug Interactions
- potentiates effects of alcohol and other anticholinergics - MAOIs prolong anticholinergic effects of diphenhydramine |
|
|
DIPHENHYDRAMINE (BENADRYL)
How Supplied |
How Supplied
- tablet: 25, 50 mg - capsules: 25, 50 mg - 50 or 100 mg prefilled syringes, vials (IV or IM) - elixir 12.5 mg / 5 ml |
|
|
DIPHENHYDRAMINE (BENADRYL)
Dosage and Administration |
Dosage and Administration
- adult: 25-50 mg IM or IV or PO - pediatric: 1-2 mg/kg IV, IO slowly or IM - if given PO: 5 mg / kg / 24 hours |
|
|
DIPHENHYDRAMINE (BENADRYL)
Duration of Action |
Duration of Action
- onset: 15-30 minutes - peak effect: 1 hour - duration: 3-12 hours |
|
|
DIPHENHYDRAMINE (BENADRYL)
Special Considerations |
Special Considerations
- if used in anaphylaxis, often used in conjunction with epinephrine and steroids |
|
|
EPINEPHRINE (ADRENALINE)
Class: |
Class:
- sympathomimetic |
|
|
EPINEPHRINE (ADRENALINE)
Mechanism of Action |
Mechanism of Action
- direct acting alpha and beta agonist § Alpha: bronchial, cutaneous, renal and visceral arteriolar vasoconstriction § Beta 1: positive inotropic and chronotropic actions, increases automaticity § Beta 2: bronchial smooth muscle relaxation and dilation of skeletal vasculature - blocks histamine release |
|
|
EPINEPHRINE (ADRENALINE)
Indications |
Indications
- patient with absent vital signs and either ventricular fibrillation or ventricular tachycardia on the cardiac monitor - cardiac arrest patient presenting in asystole on cardiac monitor but does not meet standard criteria for determination of death - patient with cardiac electrical activity on the cardiac monitor but absent vital signs or evidence of spontaneous circulation - cardiac arrest, asystole, PEA, VF unresponsive to initial defibrillation - severe bronchospasm, asthma, bronchiolitis - anaphylaxis, acute allergic reactions |
|
|
EPINEPHRINE (ADRENALINE)
Contraindications |
Contraindications
- cardiac arrest due to hypothermia - hypertension, pulmonary edema/CHF, coronary insufficiency, hypovolemic shock - narrow angle (congestive) glaucoma (Relative contraindication) |
|
|
EPINEPHRINE (ADRENALINE)
Adverse Reactions |
Adverse Reactions
- hypertension, dysrhythmias, pulmonary edema/congestive heart failure, anxiety, psychomotor agitation, nausea, angina, headache, restlessness - overdose or inadvertent IV injection of epinephrine may cause CNS hemorrhage resulting from the sharp rise in BP |
|
|
EPINEPHRINE (ADRENALINE)
Drug Interactions |
Drug Interactions
- potentiates other sympathomimetics - deactivated by alkaline solutions - MAOIs and bretylium may potentiate effects of epinephrine |
|
|
EPINEPHRINE (ADRENALINE)
How Supplied |
How Supplied
- 1 mg/ml (1:1,000) or 0.1mg/ml (1:10,000) ampules and prefilled syringes - auto-injector Epipen © 1.0 mg/ml (1:1,000) designed to deliver 0.3 mg - auto-injector Epipen Jr© 0.5 mg/ml (1:2,000) designed to deliver 0.15 mg - 0.01 mg/ml (1:100,000) also available |
|
|
EPINEPHRINE (ADRENALINE)
Dosage and Administration Cardiac Arrest Adult: |
Cardiac Arrest
Adult: - 1 mg IV push q 3 – 5 minutes prn - endotracheal: 2 mg diluted in 10 ml normal saline q 3 – 5 minutes prn |
|
|
EPINEPHRINE (ADRENALINE)
Dosage and Administration Cardiac Arrest Pediatric and Adolescent (< 16 years of age): |
Pediatric and Adolescent (< 16 years of age):
- IV/IO: 0.1 mg/kg repeated q 3 – 5 minutes prn - ET: 0.1 mg/kg diluted in normal saline to a total of 3 – 5 ml repeat q 3 – 5 minutes prn |
|
|
EPINEPHRINE (ADRENALINE)
Dosage and Administration Anaphylaxis Adult: |
Adult:
- > 6 years of age: 0.3 mg IM using EpiPen© (or equivalent delivery device) - dose may be repeated once in 10 – 15 minutes for persistent or recurrent symptoms |
|
|
EPINEPHRINE (ADRENALINE)
Dosage and Administration Anaphylaxis Pediatric and Adolescent (< 16 years of age): |
Pediatric and Adolescent (< 16 years of age):
- 1 – 5 years of age: 0.15 mg IM, using EpiPen Jr.© (or equivalent delivery device) - 6 – 15 years of age: 0.3 mg IM, using EpiPen© (or equivalent delivery device) - dose may be repeated once in 10 – 15 minutes for persistent or recurrent symptoms |
|
|
EPINEPHRINE (ADRENALINE)
Duration of Action |
Duration of Action
- onset: immediate - peak effect: minutes - duration: several minutes |
|
|
EPINEPHRINE (ADRENALINE)
Special Considerations |
Special Considerations
- pregnancy safety: category C - syncope in asthmatic children - if given via ET tube, may dilute in sterile NS (10 ml in adults) |
|
|
GLUCAGON
Class |
Class
- hyperglycemic agent, pancreatic hormone, insulin antagonist |
|
|
GLUCAGON
Mechanism of Action |
Mechanism of Action
- increases blood glucose by stimulating glycogenesis (converts liver glycogen to glucose) - unknown mechanism of stabilizing cardiac rhythm in beta- or calcium-channel blocker overdose - minimal positive inotrope and chronotrope - decreases GI motility and secretions - smooth muscle relaxant |
|
|
GLUCAGON
Indications |
Indications
- signs and symptoms consistent with hypoglycemia - documented hypoglycemia (glucose < 4 mmol/L) - altered level of consciousness when hypoglycemia is suspected - may be used as inotropic or chronotropic agent in beta- or calcium-channel blocker overdose |
|
|
GLUCAGON
Contraindications |
Contraindications
- hyperglycemia - hypersensitivity - known pheochromocytoma (adrenal tumor that secretes excess epinephrine) |
|
|
GLUCAGON
Adverse Reactions |
Adverse Reactions
- nausea & vomiting (occasional) - tachycardia, hypertension |
|
|
GLUCAGON
Drug Interactions |
Drug Interactions
- incompatible in solution with most other substances - no significant drug interactions with other emergency medications |
|
|
GLUCAGON
How Supplied |
How Supplied
- 1 mg ampules (requires reconstitution with diluent provided) |
|
|
GLUCAGON
Dosage and Administration Adult and Adolescent |
Adult and Adolescent (= 10 years of age):
- 1 mg IM |
|
|
GLUCAGON
Dosage and Administration Pediatric (< 10 years of age): |
Pediatric (< 10 years of age):
- 0.03 mg/kg IM (maximum 0.5 mg) |
|
|
GLUCAGON
Duration of Action |
Duration of Action
- onset: 1 minute - peak effect: 30 minutes - duration: variable (60 – 90 minutes) |
|
|
GLUCAGON
Special Considerations |
Special Considerations
- pregnancy safety: category C - ineffective if glycogen stores depleted (chronic alcohol related liver disease) - should always be used in conjunction with 50% dextrose whenever possible - if patient does not respond to second dose glucagons, 50% dextrose must be administered |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Class |
Class
- hyperglycemic agent |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Mechanism of Action |
Mechanism of Action
- provides quickly absorbed glucose to increase blood glucose levels |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Indications |
Indications
- conscious patients with suspected signs and symptoms consistent with hypoglycemia - documented hypoglycemia (glucose < 4 mmol/L) |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Contraindications |
Contraindications
- decreased level of consciousness, absent gag reflex, nausea, vomiting |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Adverse Reactions |
Adverse Reactions
- nausea & vomiting |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Drug Interactions |
Drug Interactions
- none |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
How Supplied |
How Supplied
- glucose pastes and gels in various forms |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Dosage and Administration Adult and Adolescent (> 10 years of age): |
Adult and Adolescent (> 10 years of age):
- 50 grams |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Dosage and Administration Pediatric (< 10 years of age): |
Pediatric (< 10 years of age):
- 25 grams |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Duration of Action |
Duration of Action
- onset: immediate - peak effect: variable - duration: variable |
|
|
GLUCOSE – ORAL (GLUCOLA, INTRA-GLUCOSE)
Special Considerations |
Special Considerations
- as noted in indications section |
|
|
NALOXONE (NARCAN)
Class |
Class
- narcotic antagonist |
|
|
NALOXONE (NARCAN)
Mechanism of Action |
Mechanism of Action
- competitive inhibition at narcotic receptor sites - reverse respiratory depression secondary to depressant drugs - completely inhibits the effect of morphine - no pharmacologic activity at all in the absence of narcotic agents |
|
|
NALOXONE (NARCAN)
Indications |
Indications
- opiate overdose or decreased level of consciousness due to opiate use - complete or partial reversal of CNS and respiratory depression induced by opioids - reverses the effects of the following: - morphine, heroin, hydromorphone (dilaudid), methadone, meperidine (demerol), fentanyl (sublimase), oxycodone (percodan), codeine, propoxyphene (darvon), butorphanol (stadol), pentazocine (talwin), nalbuphine (nubain) - coma of unknown origin |
|
|
NALOXONE (NARCAN)
Contraindications |
Contraindications
- known hypersensitivity - < 12 years of age |
|
|
NALOXONE (NARCAN)
Adverse Reactions |
Adverse Reactions
- withdrawal symptoms in the addicted patient - tachycardia, hypertension, dysrhythmias, nausea, vomiting, diaphoresis |
|
|
NALOXONE (NARCAN)
Drug Interactions |
Drug Interactions
- incompatible with bisulfite and alkaline solutions |
|
|
NALOXONE (NARCAN)
How Supplied |
How Supplied
- ampules: 0.02 mg / ml (neonate), 0.4 mg / ml, 1 mg / ml, and 2.0 mg / 5ml - prefilled syringe: ? mg / 5 ml |
|
|
NALOXONE (NARCAN)
Dosage and Administration |
Dosage and Administration
Adult and Adolescent (= 12 years of age): - 0.4 mg IV, IM, SC as an initial dose - repeat dose may be given q 3 – 5 minute prn - maximum total dose: 2.0 mg |
|
|
NALOXONE (NARCAN)
Duration of Action |
Duration of Action
- onset: within 2 minutes - oeak effect: variable - duration: life 30 - 81 minutes |
|
|
NALOXONE (NARCAN)
Special Considerations |
Special Considerations
- pregnancy safety: safety has not been established - seizures without casual relationship have been reported - may not reverse hypotension - use with caution when administering to narcotic addicts (violent behaviour, etc) - duration of action may be shorter than the effects of long acting narcotic agents. Frequent monitoring of the patient is required and repeat doses of naloxone may be necessary |
|
|
NITROGLYCERIN
Class |
Class
- vasodilator |
|
|
NITROGLYCERIN
Mechanism of Action |
Mechanism of Action
- sooth muscle relaxant acting on vascular, bronchial, uterine and intestinal smooth muscle - dilation of arterioles and veins in the periphery, reduces preload and afterload, decreases the workload of the heart and thereby decreases myocardial oxygen demand |
|
|
NITROGLYCERIN
Indications |
Indications
- adult patients with complaint of chest pain that is suspected to be of ischemic origin (see appendix of Nitroglycerine for Ischemic Chest Pain protocol) - patient with shortness of breath and crackles in both lungs (see appendix 1 of Pulmonary Edema Nitroglycerine protocol) - hypertension, congestive heart failure |
|
|
NITROGLYCERIN
Contraindications |
Contraindications
- known or suspected sensitivity to nitroglycerine - systolic blood pressure < 100 mm Hg. - Sildefanil (Viagra) use within 24 hours - intracranial bleeding or head injury |
|
|
NITROGLYCERIN
Adverse Reactions |
Adverse Reactions
- headache, hypotension, syncope, reflex tachycardia, flushing - nausea, vomiting, diaphoresis, muscle twitching |
|
|
NITROGLYCERIN
Drug Interactions |
Drug Interactions
- additive effect with other vasodilators - potent, refractory hypotension occurs when sildefanil (Viagra) used within 24 hours - incompatible with other drugs when given IV |
|
|
NITROGLYCERIN
How Supplied |
How Supplied
- tablets: , 0.3 mg, - spray: 0.4 mg per spray - patch: 0.2 mg/h |
|
|
NITROGLYCERIN
Dosage and Administration Adult: |
Dosage and Administration
Adult: - tablets: 0.3 SL (maximum 3 doses) - may be repeat q 5 minutes (discontinue if pain relieved or BP drops below 100 mm Hg systolic) Note: in the even of prolonged transport times, additional doses of nitroglycerine may be administered with orders from physician via online medical control or by prior expressed written instructions from the Medical Director. - spray: 0.4 mg SL (maximum 3 doses) - may be repeated q 5 minutes (discontinue if pain relieved or BP drops below 100 mm Hg systolic) |
|
|
NITROGLYCERIN
Duration of Action |
Duration of Action
- onset: 1 - 3 minutes - peak effect: 5 - 10 minutes - duration: 20 - 30 minutes |
|
|
NITROGLYCERIN
Special Considerations |
Special Considerations
- pregnancy safety: category C - hypotension more common in geriatric population - decomposes if exposed to light or heat - must be kept in airtight containers - active ingredient may have stinging effect when administered SL - caution with use in right sided and inferior MIs |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
Class |
Class
- inhaled gaseous analgesic and general anesthetic |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
Mechanism of Action |
Mechanism of Action
- exact mechanism unknown |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
Indications |
Indications
- acute pain due to orthopedic trauma (i.e. soft tissue injury or suspected fracture), renal colic, burns, abdominal pain (not due to suspect bowel obstruction) - moderate to severe pain - anxiety, apprehension |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
Contraindications |
Contraindications
- head injury with altered level of consciousness - recent ingestion of liquor or illicit drugs - major facial injuries or trauma - known or suspect bowel obstruction - known or suspected cardiac ischemic chest pain - patient developing cyanosis or respiratory distress with use of nitrous oxide – oxygen - inability to comply with instructions regarding use of nitrous oxide - oxygen - pulse oximeter reading indicating oxygen saturation is < 90% prior to nitrous oxide – oxygen mixture use - decompression sickness (nitrogen narcosis, air embolism, air transport) - undiagnosed abdominal pain or marked distention, cyanosis, chest trauma with pneumothorax |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
Adverse Reactions |
Adverse Reactions
- dizziness, apnea - expansion of gas-filled pockets - cyanosis, nausea, vomiting, malignant hyperthermia, drowsiness, euphoria |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
Drug Interactions |
Drug Interactions
- none of significance |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
How Supplied |
How Supplied
- D and E cylinders (blue and green) of 50% nitrous oxide and 50% oxygen compressed gas |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
Dosage and Administration |
Dosage and Administration
Adult: - instruct the patient to inhale deeply through the demand valve and mask or mouth piece Note: invert and mix contents of cylinder several times before use – follow manufacturer’s recommendations |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
Duration of Action |
Duration of Action
- onset: 2 - 5 minutes - peak effect: variable - duration: 2 – 5 minutes |
|
|
NITROUS OXIDE – OXYGEN: 50:50 mixture (NITRONOX, ENTONOX)
Special Considerations |
Special Considerations
- pregnancy safety: nitrous oxide increases the incidence of spontaneous obortion - ventilate patient area during use - nitrous oxide is a non-flammable and non-explosive gas - nitrous oxide is ineffective in 20% of the population |
|
|
OXYGEN
Class |
Class
- naturally occurring atmospheric gas |
|
|
OXYGEN
Mechanism of Action |
Mechanism of Action
- reverses hypoxemia |
|
|
OXYGEN
Indications |
Indications
- confirmed or expected hypoxemia - ischemic chest pain - respiratory insufficiency - prophylactically during air transport - confirmed or suspected carbon monoxide poisoning - all other causes of decreased tissue oxygenation - decreased level of consciousness |
|
|
OXYGEN
Contraindications |
Contraindications
- certain patients with COPD, emphysema who will not tolerate oxygen concentrations over 35% - hyperventilation |
|
|
OXYGEN
Adverse Reactions |
Adverse Reactions
- decreased level of consciousness and respiratory depression in patients with chronic CO2 retention - retrolental fibroplasias if given in high concentrations to premature infants |
|
|
OXYGEN
Drug Interactions |
Drug Interactions
- none |
|
|
OXYGEN
How Supplied |
How Supplied
- oxygen cylinders (usually green and white) of 100% compressed oxygen gas |
|
|
OXYGEN
Dosage and Administration Adult |
Adult
- cardiac arest and carbon monoxide poisoning: 100% - hypoxemia: 10 – 15 L via non-rebreather mask - COPD: 1 – 2 L / minute via nasal cannula or 28 – 35% venturi mask (be prepared to support ventilations if higher concentrations of oxygen needed |
|
|
OXYGEN
Dosage and Administration Pediatric |
Pediatric
- cardiac arrest and carbon monoxide poisoning: 100% - hpoxemia: 10 – 15 L via non-rebreather mask - COPD: 1 – 2 L / minute via nasal cannula or 28 – 35% venturi mask (be prepared to support ventilations if higher concentrations of oxygen needed Note: exception to above pediatric doses in premature infant |
|
|
OXYGEN
Duration of Action |
Duration of Action
- onset: immediate - peak effect: not applicable - duration: less than 2 minutes |
|
|
OXYGEN
Special Considerations |
Special Considerations
- be familiar with liter flow and each type of delivery device used - supports combustion |
|
|
SALBULTAMOL (VENTOLIN)
Class |
Class
- sympathomimetic, bronchodilator |
|
|
SALBULTAMOL (VENTOLIN)
Mechanism of Action |
Mechanism of Action
- selective ß2 agonist which stimulates adrenergic receptors of the sympathomimetic nervous system, resulting in smooth muscle relaxation in the bronchial tree and peripheral vasculature - little action of ß1 receptors in cardiac muscle |
|
|
SALBULTAMOL (VENTOLIN)
Indications |
Indications
- patients with signs or symptoms of respiratory distress (see Bronchospasm protocol) - treatment of bronchospasm in patients with reversible obstructive airway disease (COPD / asthma) |
|
|
SALBULTAMOL (VENTOLIN)
Contraindications |
Contraindications
- < 1 year of age |
|
|
SALBULTAMOL (VENTOLIN)
Adverse Reactions |
Adverse Reactions
- restlessness, tremors, dizziness, palpitations, tachycardia, nervousness, peripheral vasodilation, nausea, vomiting, hyperglycemia, increased blood pressure and paradoxical bronchospasm - synergistic with other sympathomimetics |
|
|
SALBULTAMOL (VENTOLIN)
Drug Interactions |
Drug Interactions
- tricyclic antidepressants and MAOIs may potentiate effects on vasculature - use with caution - beta-blockers are antagonistic - may potentiate hypokalemia caused by diuretics |
|
|
SALBULTAMOL (VENTOLIN)
How Supplied |
How Supplied
- packaged, prepared nebulas (2.5 mg) - metered dose inhaler: 90 mcg / metered spray (17 gram canister with 200 inhalations) |
|
|
SALBULTAMOL (VENTOLIN)
Dosage and Administration Adult: |
Dosage and Administration
Adult: - administer 2.5 mg inhalation with 2.5 ml normal saline in nebulizer - second dose may be given q 15 minutes prn - subsequent repeat doses may be given q 15 minutes prn |
|
|
SALBULTAMOL (VENTOLIN)
Dosage and Administration Pediatric: |
Pediatric:
- administer 2.5 mg inhalation with 2.5 ml normal saline in nebulizer - second dose may be given q 15 minutes prn - subsequent repeat doses may be given q 15 minutes prn |
|
|
SALBULTAMOL (VENTOLIN)
Duration of Action |
Duration of Action
- onset: 5 - 15 minutes - peak effect: 60 - 90 minutes - duration: 3 - 6 hours |
|
|
SALBULTAMOL (VENTOLIN)
Special Considerations |
Special Considerations
- pregnancy safety: has been used in pregnant women for many years without apparent ill consequence - antagonized by beta-blockers - may precipitate angina pectoris and dysrhythmias - should only be administered by inhalation methodology in out -of-hospital management |
